InVivo Therapeutics Announces Presentation at the Upcoming H.C Wainwright Virtual Global Investment Conference
About InVivo Therapeutics
InVivo Therapeutics (Nasdaq: NVIV) is a clinical-stage biotechnology company focused on redefining the treatment of spinal cord injury. InVivo’s proprietary and investigational Neuro-Spinal Scaffold, based on technology licensed from Robert S. Langer’s lab at Massachusetts Institute of Technology, is in pivotal clinical studies for acute spinal cord injury. The company is headquartered in Cambridge, MA. For more details, visit www.invivotherapeutics.com.
Bret Shapiro, Managing Partner
Source: InVivo Therapeutics Holdings Corp.